Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-060558
Filing Date
2025-04-30
Accepted
2025-04-30 07:00:11
Documents
1
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3983
  Complete submission text file 0000950170-25-060558.txt   5408
Mailing Address C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025
Business Address
HILLEMAN JERYL L (Reporting) CIK: 0001216628 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41365 | Film No.: 25890853

Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Issuer) CIK: 0001888012 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)